Diosgenin Ameliorated Type II Diabetes-Associated Nonalcoholic Fatty Liver Disease through Inhibiting De Novo Lipogenesis and Improving Fatty Acid Oxidation and Mitochondrial Function in Rats

Diosgenin (DIO) is a dietary and phytochemical steroidal saponin representing multiple activities. The present study investigated the protective effect of DIO on type II diabetes-associated nonalcoholic fatty liver disease (D-NAFLD). The rat model was established by high-fat diet and streptozotocin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Yujie, Li, Zhiman, Jin, Ruyi, Yao, Yanpeng, He, Silan, Lei, Min, Wang, Xin, Shi, Chao, Gao, Li, Peng, Xiaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738614/
https://www.ncbi.nlm.nih.gov/pubmed/36501024
http://dx.doi.org/10.3390/nu14234994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738614/
https://www.ncbi.nlm.nih.gov/pubmed/36501024
http://dx.doi.org/10.3390/nu14234994

Ejemplares similares